Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuemei Wang

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Scientific Reports|July 18, 2024
Author Correction: Increased risk of fetal left-right asymmetry disorders associated with maternal SARS-CoV-2 infection during the first trimesterYang Li, Yuemei Wang, Haifang Wu, et al.
Frontiers in Pediatrics|July 31, 2023
Cleft palate in fetuses: feasibility of early diagnosis by Crystal and Realistic Vue rendering 3D ultrasound technology in the first trimesterZhihong Shi, Huaxuan Wen, Junhong Leng, et al.
Frontiers in Immunology|January 27, 2025
Inhibition SIRT1 to regulate FOXP3 or RORγt can restore the balance of Treg/Th17 axis in ulcerative colitis and enhance the anti-inflammatory effect of moxibustionYuanbing Zhu, Yuemei Wang, Xiaotong Zuo, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy <i>via</i> regulation of TFRC-dependent ferroptosisWenjing Yu, Yuehuai Hu, Zhiping Liu, et al.
Frontiers in Pharmacology|August 29, 2022
Up-and-coming anti-epileptic effect of aloesone in <i>Aloe vera</i>: Evidenced by integrating network pharmacological analysis, <i>in vitro</i>, and <i>in vivo</i> modelsYan Wang, Chang Li, Zhongyv Xiong, et al.
Journal of Hazardous Materials|March 18, 2026
Decoding the adaptive strategies of versatile diazotrophs to multi-metal(loid) stress in mercury-mining impacted farmland soilsXiaomi Wang, Ling Zhao, Ying Teng, et al.
Gynecologic Oncology|March 6, 2024
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancerDebra L Richardson, Kathleen N Moore, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 10, 2024
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trialRobert L Coleman, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Scientific Reports|July 18, 2024
Author Correction: Increased risk of fetal left-right asymmetry disorders associated with maternal SARS-CoV-2 infection during the first trimesterYang Li, Yuemei Wang, Haifang Wu, et al.
Frontiers in Pediatrics|July 31, 2023
Cleft palate in fetuses: feasibility of early diagnosis by Crystal and Realistic Vue rendering 3D ultrasound technology in the first trimesterZhihong Shi, Huaxuan Wen, Junhong Leng, et al.
Frontiers in Immunology|January 27, 2025
Inhibition SIRT1 to regulate FOXP3 or RORγt can restore the balance of Treg/Th17 axis in ulcerative colitis and enhance the anti-inflammatory effect of moxibustionYuanbing Zhu, Yuemei Wang, Xiaotong Zuo, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy <i>via</i> regulation of TFRC-dependent ferroptosisWenjing Yu, Yuehuai Hu, Zhiping Liu, et al.
Frontiers in Pharmacology|August 29, 2022
Up-and-coming anti-epileptic effect of aloesone in <i>Aloe vera</i>: Evidenced by integrating network pharmacological analysis, <i>in vitro</i>, and <i>in vivo</i> modelsYan Wang, Chang Li, Zhongyv Xiong, et al.
Journal of Hazardous Materials|March 18, 2026
Decoding the adaptive strategies of versatile diazotrophs to multi-metal(loid) stress in mercury-mining impacted farmland soilsXiaomi Wang, Ling Zhao, Ying Teng, et al.
Gynecologic Oncology|March 6, 2024
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancerDebra L Richardson, Kathleen N Moore, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 10, 2024
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trialRobert L Coleman, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
Pageof 4